How melittin antitumor activity has been studied, and it has been found that melittin may increase the death of hepatocellular carcinoma cells (HCC) through the CAMKII-TAK1-JNK/p38 system. This evidence concerns the gene MAPK8 and hepatocellular carcinoma.